An interventional study of Aranet4 Home CO2 monitor in Healthcare Associated Infection, sponsored by Imelda Hospital, Bonheiden. Completed at 1 site in Belgium. Per ClinicalTrials.gov, last updated 2021-05-11.
Sponsored by Imelda Hospital, Bonheiden · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Ventilation with fresh outdoor air has recently gained considerable attention as a means to reduce the potential risk of indoor aerosol transmission of respiratory pathogens such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus causing coronavirus disease 2019 (COVID-19). Commercial carbon dioxide (CO2) monitors are increasingly used in schools, long-term care facilities, offices and public buildings to monitor indoor ventilation. However, no formal evidence is available to support the effectiveness of feedback from CO2 monitoring devices. Moreover, modern hospitals have superior indoor air quality control systems.
The aim of this prospective pilot randomized controlled trial (RCT) is to evaluate whether CO2 monitoring devices would be useful as a means to further maintain lower indoor CO2 concentrations in hospitals.
In this pilot, randomized, sham-controlled open-label RCT, hospital rooms will be fitted with Aranet4 Home CO2 sensors.
Each device will continuously measure indoor CO2 concentrations at 1-minute intervals during 4 time periods:
2-3. Sham/Intervention period: sensors on the same ward will be randomized to placebo (sensor not showing CO2 levels to staff) or Intervention (sensor displaying CO2 levels to staff) in a cross-over design
Each measurement period will consist of 7 days with no washout period.
Our primary hypothesis is that CO2 sensors will record less time (minutes) with elevated CO2 levels during the intervention period, compared to the Sham periods. However, carry-over effects will be investigated by comparing the Intervention periods to the Baseline and Post-intervention phases.
Note [February 27, 2021]: due to technical problems with the Aranet4 device Bluetooth connection, outcome data will be analyzed according to measurement data at 2-5 minute intervals (measurements can be made every minute, but data cannot be downloaded with the current version of the app due to technical problems).
287 studies on the registry are indexed under Cross Infection; 47 are open to participants now.
This study's enrollment of 12 is below the median of 193 across 170 interventional studies indexed under Cross Infection.
Browse Cross Infection studies →Imelda Hospital, Bonheiden is the lead sponsor of 7 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
CO2 values on sensor visible to staff
Device: Aranet4 Home CO2 monitor
CO2 values on sensor not visible to staff
Device: Aranet4 Home CO2 monitor
The sensor is placed in the room at a height between 1 and 2 meters and not near the window or door.
Time >800 ppm CO2
Time/day (in minutes/24h) measuring \>800 ppm CO2
Time frame: 7 days/time period (pre-, active/sham and post-intervention)
Time >1000 ppm CO2
Time/day (in minutes/24h) measuring \>1000 ppm CO2
Time frame: 7 days/time period (pre-, active/sham and post-intervention)
Time >1400 ppm CO2
Time/day (in minutes/24h) measuring \>1400 ppm CO2
Time frame: 7 days/time period (pre-, active/sham and post-intervention)
Daily peak CO2 concentration [in ppm]
Daily peak CO2 concentration \[in ppm\]
Time frame: 7 days/time period (pre-, active/sham and post-intervention)
Staff-rated feasibility on a 10-point Likert scale [0-10, with 10 indicating better outcome]
How feasible is it to use CO2 sensors to monitor indoor air quality in hospital? Anonymous online survey during the post-intervention phase
Time frame: 7 days
Staff-rated preference on a 10-point Likert scale [0-10, with 10 indicating better outcome]
Would you prefer to use CO2 sensors to monitor indoor air quality in hospital in the future? Anonymous online survey during the post-intervention phase
Time frame: 7 days
Plan to share: Yes — The full set of sensor data will be made available to established investigators upon simple request.
Supporting information: Study protocol, Statistical analysis plan, Analytic code
Time frame: Data will be available upon fulltext print publication in a peer-reviewed journal, for a duration of at least 10 years.
Access criteria: Simple e-mail request to the corresponding author by an established scientific investigator
Ran from Feb 2021 to primary completion in May 2021, 2 months.
Of 59 non-industry interventional studies with no phase under Cross Infection, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 29. This study's 2 months is below that.
Counting every sponsor, half of 61 studies reached it within 16 months; a quarter within 7 and three quarters within 29.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in May 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Imelda Hospital, Bonheiden